Advertisement

FDA Approves Nucala for Chronic Obstructive Pulmonary Disease

0

Approval is for adult patients with COPD with eosinophilic inflammation

Severe Exacerbations Down With As-Needed Albuterol-Budesonide for Mild Asthma

0

Severe exacerbation occurred in fewer patients receiving albuterol-budesonide versus those receiving albuterol only

Intravenous Tenecteplase Beneficial Before Endovascular Thrombectomy

0

Higher functional independence seen at 90 days for patients with acute ischemic stroke due to large vessel occlusion who present within 4.5 hours

FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs

0
By I. Edwards HealthDay Reporter FRIDAY, May 23, 2025 (HealthDay News) — A federal deadline ending the sale of off-brand weight-loss and diabetes medications is...

Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease

0

Patients with HSV-1 who used antiherpetics were less likely to develop Alzheimer disease than those who did not

Half of Youth-Serving Clinicians Screen for Substance Use Disorder at Every Well Visit

0

Fewer report using a screening tool at every well visit

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

0
By I. Edwards HealthDay Reporter THURSDAY, May 22, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to...

Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics

0

Residual inflammation significantly linked to higher BMI, metabolic dysfunction-associated steatotic liver disease, baseline systemic inflammation

Lipoprotein(a) Levels Tied to Increased Risk of Recurrent Atherosclerotic CVD Events

0

Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy

FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups

0
By I. Edwards HealthDay Reporter WEDNESDAY, May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and...